Pfizer has already made its biggest deals, Bourla says
If analysts and investors think that Pfizer has a trick up its sleeve to further acquire its way to growth, CEO Albert Bourla assured them it does not. The company has about $6 billion to ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
